Xiamen Amoytop Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Xiamen Amoytop Biotech has a total shareholder equity of CN¥2.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.4B and CN¥390.8M respectively. Xiamen Amoytop Biotech's EBIT is CN¥770.8M making its interest coverage ratio -94.7. It has cash and short-term investments of CN¥424.8M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -94.7x |
| Cash | CN¥424.77m |
| Equity | CN¥2.01b |
| Total liabilities | CN¥390.79m |
| Total assets | CN¥2.40b |
Recent financial health updates
No updates
Recent updates
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors
Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%
Sep 19Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?
Jun 12Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 04Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk
Mar 25Financial Position Analysis
Short Term Liabilities: 688278's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥315.0M).
Long Term Liabilities: 688278's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥75.8M).
Debt to Equity History and Analysis
Debt Level: 688278 is debt free.
Reducing Debt: 688278 has no debt compared to 5 years ago when its debt to equity ratio was 11.2%.
Debt Coverage: 688278 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688278 has no debt, therefore coverage of interest payments is not a concern.